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Executive Summary.
 
The Fourteenth Seminar on Tropical Medicine was conducted under the
 
ausoic:es of the Institute of Tropical Medicine, Yonshei University and
 
supported by the Ministry of Health and Social Affairs, Republic of Korea,
 
The Korea Medical Association and the Korean Overseas Construction
 
As:ociation. The Conference was helri at Chiang, Kee Won Memorial Hall,
 
Yonshei University, Seoul, Korea on 9-11 June, 1983.
 
The main theme of the semi.iar was "Control of Currently Important 
Tropical Diseases". The seminar consisted of the presentation of review 
papers and original free papers, and two panel discussions. Attendees at 
the seminar included scientists from various countries (see appendix A) 
who are engaged in research in basic and applied medical sciences concerning 
parasitic and microbial diseases and in public health and epidemiological 
studies. 
The seminar consisted of four (4)main sections: 1). advances in
 
immunodiagnosis, 2). new developments in treatment of tropical diseases,
 
3). biological control of vectors and intermediates of tropicdl diseases and
 
4). other scientific free papers.
 
This consultant acted as a resource person serving as a member of the
 
organizing committee, presently two (2) scientific papers (see Introduction and
 
Methodology section), serving as moderator for section on "Biology and Control
 
of Intermediates" and sharing presentation of paper entitled Bulinus truncatus
 
in Jordan with Dr. A. Buck in absence of originally scheduled presenter, Dr. E.
 
Saliba.
 
Several timely and important scientific presentations were made during
 
the seminar. These included: 1) recent advances in immunodiagnosis of tropical
 
diseases, by Dr. John H. Cross, Scientific Director, U. S. Naval Medical
 
Research Unit. No. 2 (NAMRU-2) APO S.F. CA. 96528, 2) treatment of trematode
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infections by Dr. Han-Jong Rim, 
 Professor, Department of Parasitology,
 
Korea University Coll-ege of Medicine, 3) Epidemiology of concomitant
 
disease by Dr. Alfred Buck, Tropical Disease Advisor, Office of Health,
 
Agency for International Development, Washington, D.C., 4) The emerging
 
problem of drug resistance in treatment of schistosomiasis by Dr. John
 
I. Bruce (this consultant), Professor of Biological Sciences, and Director
 
of Center for Tropical Diseases, University of Lowell, Lowell, MA,
 
5) Control of Schistosomiasis throughout Japan today by Dr. George W. Hunter,
 
III, Clinical Professor, Department of Community and Family Medicine,
 
Division of Epidemiology, University of California School of Medicine, Cal­
ifornia and 6) Biological control of vectnrs and intermediates in Southeast
 
Asia by Dr. Chamlong Harinasuta, Professor, Faculty of Tropical Medicine,
 
Mahidol University, Bangkok, Thailand.
 
The special session on Hepatitis B virus infection highlighted the
 
Republic of Korea's efforts in producing and testing of the new Hepatitis
 
B virus vaccine with information concerning the problems and logistics of
 
immunization procedures. Information concerning certain aspects of the
 
disease in Thailand, Ugunda, Philippines and Taiwan were also presented.
 
The two panel discussion sessions, namely session I; Biological Control
 
of Vectors oF Tropical Diseases and session II; Strategy in Health Problems
 
were especially well organized and provided current and up to date information
 
which was valuable to conference participants.
 
The series of Tropical Medicine seminars organized under the leadership 
of Dr. Chin-Tak Soh of Korea since 1969 has served as an 
important forum and
 
source of current information for scientists in Southeast Asia and Asia proper.
 
The annual seminar brings together scientists from Asia at a site which is
 
economical and convenient for them to reach. Many young scientists from Asia
 
have been given an opportunity to attend these meetings and to meet with senior
 
scientists whom they would never have the chance to meet otherwise. The annual
 
seminar is therefore a very important event for the scientific community of Asia.
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I. Introduction.
 
A. 	Purpose of the Assignment.
 
The purpose of the assignment was to attend "The Fourteenth
 
Seminar on Tropical Medicine" for the purpose of serving as a resource
 
person with particular reference to schistosomiasis.
 
B. 	Scope of work task. 
The assignment consisted of serving as a member of organizing 
committee, presenting two (2) scientific papers, serving as moderator for 
the afternoon session dealing with the "Biology and Control of Intermediates", 
filling in when appropriate for scheduled participants who were unable to 
attend the conference and aid during a post-conference period the organization
 
of documents for publication of conference proceedings.
 
C. Itinerary. 
June 8 - Pre-conference meeting with members of organizing 
committee. Assisted in rearrangement of certain 
conference sections due to absence of scheduled 
participants, 2) planned post-conference meeting 
to discuss organization of seminar proceedings 
publication. 
June 9 - Attendance at seminar. 
June 10 - Shared in presentation of scientific paper No. 26 
entitled "Bulinus truncatus in Jordan". 
Presented scientific paper No. 27 A entitled "The 
Emerging Problem of Drug Resistance in Treatment 
of Schistosomiasis".
 
Presented scientific paper No. 31 entitled "Recent
 
Advances in the Biological Control of Snail
 
Intermediate Host of Trematode".
 
Served as moderator for entire afternoon session
 
entitled "Biological Control of Intermediates".
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June 11 - Attendance at seminar. 
June 12 - Post-Conference working meeting to organize
 
seminar proceedings publication at Yonshei
 
University.
 
June 13 - Meeting with chairman of organizing committee and
 
staff of Institute of Tropical Medicine at
 
Yonshei University.
 
D. 	Methodology.
 
The assignment consisted of serving as resource person at the
 
seminar. 
 The methodology in this instance involved the presentation of
 
scientific papers and serving as moderator for an afternoon session.
 
The scientific papers presented were as follows.
 
1. 	The Emerging Problem of Drug Resistance in the Treatment
 
of Schistosomiasis.
 
2. 	Bulinus truncatus in Jordan (summary of subject shared with
 
Dr. A. Buck in absence of scheduled participant, Dr. Saliba
 
from Jordan.
 
3. Recent Advances in the Biological Control of Snail
 
Intermediate Host of Trematodes.
 
The complete text of each of the above presentations
 
are enclosed in Appendix B.
 
2. 	 Conclusion 
The Fourteenth Seminar on Tropical Medicine was well organized and 
of substantial quality. The quality of many of the papers presented was excellent,
 
timely and of current contents. Several of the presentations and/or panel dis­
cussions were considered to be very outstanding both in content and of relevance
 
to the seminars theme.
 
The seminar is considered to be of relevant'scientific importance to
 
the scientific community of Asia.
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Papers Presented at Seminar
 
1. 	The Emerging Problem of Drug Resistance in Treatment of
 
Schistosomiasis.
 
2. 	Bulinus truncatus in Jordan.
 
3. 	Recent Advances in the Biological Control of Snail
 
Intermediate Host of Trematodes.
 
1. THE EMERGING PROBLEM OF DRUG RESISTANCE IN TREATMENT OF SCHISTOSOMIASIS
 
Drug resistance can be defined as the transitory or permanent loss of the
 
initial sensitivity of microorganisms or mammalian cells to the effect of sub­
stances which interfere with vital functions of these structures. It manifests
 
itself after the exposure to the agent in vitro or in-vivo. More recent
 
developments in this area might justify a further simplification of this state­
ment in the words of Lamy as the "sudden or gradual, permanent or transient
 
loss of the originally present susceptibility to a chemical compound".
 
The first observation that certain microorganisms could become resistant
 
to drugs which they were formerly sensitive was made by Ehlich for trypanosomes.
 
Subsequently, many microorganisms such as bacteria, viruses, spirochetes, fungi,
 
richettsia and protozoa such as malaria, entameba, coccidiosis among others were
 
shown to be able to develop resistance to therapeutic agents. The problem of
 
drug resistance also occurs among arthropods.
 
During this century, the widespread use of drugs to treat and control
 
infectious organisms has almost invariably led to the development of drug
 
resistance. Inman, this problem has been a very persistant one in regard to
 
the treatment of bacteria and protozoa such as malaria, trypanosomiasis and more
 
recently leishmaniasis. Constant vigilance is maintained for the occurrance of
 
new resistant strains among protozoa and bacteria as compared to no effort for
 
the helminths which infect man.
 
Among the helminths, drug resistance has occurred from the widespread use
 
of anthelmintics to treat nematode infections in domestic animals.
 
Considerable concern has arisen in the veterinary industry in Australia because
 
of drug resistance in nematodes of sheep. The problem has already progressed
 
beyond the situation as veviewed recently by Prichard, to one where in some areas
 
the two major types of anthelmintics used no longer kill some species of nematodes.
 
The phenomenom of nematode drug resistance is not confirmed to Australia. In the
 
opinion of many scientists, the problem is now growing worse in America.
 
Based on the farmers experiences with anthelmintics especially in
 
Australia and reports of new cases, the problem with drug resistance in
 
nematodes is likely to persist. In fact, users of nematode anthelmintics
 
are now seeking alternative ways of controlling these drug-resistant nematode
 
worms.
 
Drug resistant strains of nematodes have been produced experimentally
 
(in both in vivo and in vitro systems) in the laboratory with such
 
anthelmintics as carbendazole, thiabendazole, and levamisole. For carbendazole
 
and thiabendazole, resistance has been brought about by selection of a naturally
 
drug-resistant population and the progressive elimination of drug sensitive
 
worms. In the case of levamisole and benzimizole resistance, caenorhabditis
 
elegans worm was first exposed to a mutagen and then selected with these drugs.
 
The problem of drug resistance among helminths is not limited only to
 
nematodes. The literature contains many references which refer to the wide
 
variation in results obtained from drug trails both clinically and under
 
experimental conditions concerning the susceptability of Schistosoma mansoni
 
from various geographical regions. The results of these observations showed
 
that strains of S. mansoni originating from the same region can also differ in
 
this sensitivity to anti-schistosomal drugs.
 
References to the occurrance of resistant S. mansoni strains have been
 
reported by various investigators as a result of laboratory experimentation or
 
from a combination of field and laboratory observations. These include the
 
reports by Rogers and Bueding, 1971, Katz et al 1973, Compos et al 1976, Jasma
 
et al 1977, Dias et al 1978, and Dias et al 1982. It appears that from some
 
of the reported data that the lack of susceptability observed in some strains
 
of S. mansoni cannot be solely ascribed to previous administration of anti­
schistosome drugs and thus further studies are required to elucidate this
 
phenomena.
 
Rogers and Bueding and Jasma et al showed the occurrence of genetically
 
transferred resistance to hycanthone for several strains of S. mansoni in mice.
 
It should be pointed out that the relative ease by which resistance to hycan­
thone was produced under experimental conditions may be due to the highly
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mutagenic nature of this compound. Development or selertion of resistant
 
strains may not occur as readily with other antischistosomal agents.
 
The occurrance of drug-resistant S. mansoni as a result of treatment of
 
patients was first suggested by Davis during a program in upper Egypt in 1966.
 
It was observed by clinicians that the cure rate was lower in those patients
 
undergoing a second course of treatment with niridazole than in those receiving
 
treatment for the first time, thus suggesting that perhaps drug resistance was
 
developing in the retreated group.
 
Since that time, nearly all of the reports concerning information relative
 
to the occurrance of drug resistant S. mansoni in the field from patients
 
treated with various drugs have come from Brazil.
 
In view of the current situation, there seems to be little reason to think
 
that the same problem is not occurring in other regions of the world where
 
antischistosome drugs are being used to treat patients both in clinics and on a
 
mass scale.
 
Although the rate of occurrence of drug resistant strains will depend on
 
the length of the parasite life cycle and the selection pressure used, this in
 
turn will depend on the percentage of the population treated, the frequency of
 
dosing and the efficacy of the treatment. Drugs with 100% efficacy should not
 
select for resistance, but in practice few treatments for schistosomiasis give
 
a complete cure of egg production. Whether those worms that survive are present
 
due to the pharmacology of the schistosomicide and thus the effectiveness of the
 
therapy varying between patients, or because of a natural variation in suscepti­
bility of worms to drugs is not known. If all cases were due to the for ,er
 
reason, there would be no reason for concern, but if the latter, then drug
 
resistance could be expected to emerge. In practice both situations may be
 
expected to occur in the field.
 
There is at present no information on the significance of drug resistance
 
in schistosomaisis anywhere in the world. Clearly this situation must be
 
remedied as resistance and could become a very serious problem in the control of
 
schistosomiasis. Before detailed epidemiology of resistance can be undertaken,
 
as has been performed for namatodes of sheep, basic information needs to be
 
collected. This must include a description of what resistant strains already
 
exist in the field and to what drugs these strains are resistant. This is a
 
prerequisite for the optimal clinical therapy if patients harboring resistant
 
strains. It needs also determining whether strains failing to respond to more
 
than one type of drug are present. This has been described in the nematode
 
haemonclus contortus in Australia and may be widespread. It could presumably
 
occur with S. mansoni as well.
 
In addition to searching for resistance and trying to relate cure rates to
 
presence of drug-resistant worms, we should look for alternative methods of
 
detecting resistance. The present method to be used for infection of snails
 
with eggs from patients' feces-then-mice-with cercariae-from snails and then
 
treatment of mice with drugs takes at least 12 weeks and uses large numbers of
 
animals. Alternative tests using infected snails, cercariae or schistosomula
 
should be investigated.
 
Observations concerning drug resistance S. haematobium has not been made.
 
Only one laboratory study by Hsu suggests drug resistance may occur with S.
 
japonicum worms.
 
In view of the occurrance of drug resistant schistosome following treatment
 
of patients with hycanthone, oxamniquine and niradizole, this could conceivably
 
occur with compounds which may be developed in the future. This problem then
 
poses great difficulty in the eventual development of anti-schistosomal agents.
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2. BULINUS TRUNCATUS IN JORDAN
 
The possibility of schistosomiasis occurring in Jordan was thought
 
to be minimal prior to 1975 (Saliba et al., 1976, 1980; Salaba and Salameh,
 
1981; and Saliba et al., 1981). This view was based on (1) the fact that
 
the patients who had been diagnosed as having schistosomiasis had encoun­
tered the disease outside of Jordan, presumably in neighboring countries,
 
and (2) a result of the limited surveys of Abdel Azim and Gismann (1956)
 
and Chu (1969) in which no snail vectors for the human schistosomes were
 
found.
 
In 1975 a case of urinary schistosomiasis was diagnosed at a hospital
 
by the Royal Jordanian Medical Services. Interrogation of the patient
 
revealed that he had resided primarily in the Jordan Valley and that he had
 
never left the country. Despite the fact that the autochthony of the case
 
was questionable, urine samples from 3,000 Jordanians were collected while
 
they were outpatients at the clinics in the Jordan Valley (Saliba et al.,
 
1980). The results of the examination of these samples for Schistosoma
 
haematobium ovq were negative (unplublished data).
 
Despite the fact that there are annually 75,000 - 120,000 migrant
 
workers from countries with endemic areas of schistosomiasis, there is no
 
evidence that transmission is occurring in Jordan at the present time
 
(personal communication, Ministry of Health). During the period between
 
March 1979 and April 1982, a total of 42,600 urine samples were collected
 
from migrant workers and examined for S. haematobium ova, and 10,011 were
 
found to be positive. The percent of infection was thus found to be 23.5%.
 
A total of 7,005 of the 10,011 migrant workers who were scheduled to work at
 
various agricultural tasks in the Jordan Valley were treated with the
 
antischistosomal drug, praziquantel. The remaining 3,006 infected persons
 
were scheduled to work in the greater Amman urban area and some of these
 
were treated with ambilhar and others were not treated (nersonal communication,
 
Dr. M.R. Tawfiq, Ministry of Health). In addition to urinary schistosomiasis,
 
some migrant workers undoubtedly suffer from intestinal schistosomiasis, since
 
this form of the disease is also present in their respective homelands.
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The foreign agriculture workers who reside in Jordan pose a special
 
threat in that they represent a pool of infected persons who may act as
 
a source of schistosome eggs (if those infected are not successfully
 
treated) which can be disseminated into Jordanian waters. Likewise,
 
vacationers from countries with endemic schistosomiasis also pose a
 
special public health threat. Inmany instances, there is an absence of
 
proper sanitary facilities in vacation areas and the possibility exixts
 
that vater in these areas will be contaminated with human wastes harboring
 
viable eggs.
 
Snail Intermediate Hosts for Schistosomiasis in Jordan and
 
their Ecological Considerations.
 
Because of the increased development of new water resources in Jordan,
 
significant changes in the natural hydrographic topography of Jordan are
 
presently underway. The ancient scheme of rapid movement of surface waters
 
from the mountains to the barren Dead Sea are now being compromised by water
 
resource improvements such as the East Ghor Canal and its extension, the King
 
Talal Dam, and fish farming operations. The current development of an
 
extensive system of secondary and tertiary canals to distribute water for
 
irrigation in the Jordan Valley will provide good potential habitats for the
 
establishment of vector snail populations. Chemical analyses for pH,
 
(Saliba et al., 1980) temperature, turbidity, color and alkalinity of many
 
Jordanian water resources were observed to be within the same range found in
 
snail-infested Nile River sites (Saliba et al., 1980 and Mallett and Bruce,
 
in preparation). It has been noted that those areas which recently have
 
become high probability areas for the establishment of Bulinus snails are
 
also among those areas most frequented by foreign workers who have had
 
previous exposure to Schistosoma haematobium. These areas, along with other
 
developed water resources, must be regarded as potential high risk areas.
 
The key factor in the absence of schistosomiasis in Jordan has been the
 
lack of snail intermediate hosts in the country. Vector snails had not been
 
found during earlier limited surveys for schistosome intermediate hosts in
 
Jordan (Azim and Gismann, 1956 and Chiu, 1969). However, in spite of the
 
absence of vector snails, it was felt at that time that some areas seemed
 
favorable for the establishment of Bulinus truncatus (e.g., Azraq and the
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Jordan Valley), and that future exploitation of the waters of the Yarmouk
 
and the Jordan rivers would change ecologic conditions so as to favor
 
establishment of the snails and schistosomiasis might then be introduced
 
(Rey, 1977 and Bruce et al., 1978).
 
In 1975, and after the discovery of the presumed indigenous Jordanian
 
case of schistosomiasis mentioned previously, the waters of 64 localities
 
in the Jordan Valley (excluding the Jordan River itself) were surveyed for
 
snails. The species collected were mainly members of the genera Fossaria,
 
Melanoides, Melanopsis, Physella, Radix, and Theodoxus. 
 The snail vector
 
for urinary schistosomiasis in the Middle East, Bulinus truncatus, was
 
found at only one locality. This was a cemented reservoir in the Muthalath
 
Al-Masri area about 13 km south of Dair Alla village (Saliba et al., 1974).
 
The reservoir received water periodically from the East Ghor Canal. No
 
other Bulinus snail foci were found in the Jordan Valley during that survey
 
or the subsequent limited surveys carried out in 1977 by a team from the
 
Ministry of Health or the brief survey in 1977 and 1978.
 
In 1979, a new focus of B. truncatus was located about 1.5km west of
 
the town of Jerash in a spring pool and in its drainage canal carrying water
 
to irrigate farms on the outskirts of the town (Saliba and Sal.)meh, 1981).
 
The potential for snail dispersal from this 
area to other water bodies is
 
high since water from the pool overflows in winter to the Wadi of Jerash,
 
then to the Zarqa River and the King Talal Dam, and subsequently to the Jordan
 
Valley.
 
In 1980, following construction and subsequent filling of the King
 
Talal Dam, snails identified as Bulinus truncatus, the intermediate host for
 
S. haematobium in the Middle East, were discovered in large numbers throughout
 
the dam and even in drainage or leakage areas adjacent to the dam (Saliba and
 
Rida, unpublished data).
 
Subsequent to the above discovery, Bulinus snails have been found at
 
four sites in the Jordan Valley. The sites are as follows: Shaikh Hussain,
 
Zour Al-Hamman, Tal Salman and Ain Taha (Saliba and Rida, unpublished data).
 
Bulinus shells were also recovered from two other sites in the Jordan Valley,
 
at Ain Abu Fareed and Al-Mahchia (Malaka springs).
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3. 	RECENT ADVANCES IN THE BIOLOGICAL CONTROL OF SNAIL INTERMEDIATE
 
HOST OF TREMATODES.
 
As a result of the increasing resistance against the use of chemicals
 
to control disease vectors, biological control involving the use of predators,
 
compeditors, microorganisms, and certain vertebrates has assumed a high level
 
of importance during the past decade.
 
A review of the literature dealing with biological control of snail
 
intermediate hosts reveals that there are more than several 
hundred species
 
of various forms which have been considered as potential competitors, or
 
predators such as pathogens, parasites and invertebrates and vertebrates.
 
The 	efficiency of using these various life forms as control 
agents has rarely
 
been tested outside the confines of the laboratory.
 
Comprehensive reviews discussing various aspects of biological 
control
 
of snail intermediate hosts have been published by Michelson (1957), Ferguson
 
(1972, 1978) Harrston et al, 1975 and McCullough (1981). For this presenta­
tion, the more promising biocontrol techniques will be summarized.
 
Among the various groups of predators which have been described, only two
 
species, fish and insects merit serious consideration for possible use in
 
control schemes. There are several fish species which deserve mentioning
 
(Serranochromis sp., astatoreochromis alluaudi, Tilapia melanopheura, clarias
 
sp. and various others) as possible predators. Nearly all of the observations
 
concerning effect of fish on snail populations have been made in East and Central
 
Africa and none can be regarded as conclusive and therefore there is a need for
 
curther investigation.
 
The insect most frequently cited as a possible control organism for snails
 
is the sciomyzed flies which are obligatory feeders of mollusc larvae, especially
 
in gastropods. As reviewed by Berg (1964) and Harrston et al 
(1975), there are
 
several hundred which exist with a wide range of predator/prey activity.
 
Pointier (1979) conducted field studies in Guadeloupe concerning the natural
 
enemies of Biomphalaria glabrata in a series of diverse habitats. Pointiers
 
concluded that in nature, co-existing predators such as leeches, insects,
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crustaceans do play a very crucial role in governing snail host population
 
densities particularly in small, well developed, static waterbodies as well
 
as in situations where natural enemies exist in combinations with each
 
other. The role of these organisms in reducing or eliminating schistosome
 
transmission is not one of absolute value.
 
Significant progress is being made in the use of certain species of
 
bacteria to control insects and interest now exists on the part of some
 
investigators to determine if there are species of bacteria which can be
 
used as control agents for schistosome vector snails. Studies of micro­
spordia hyperparasites of schistosome larva is in the basic exploratory
 
stage of investigation.
 
The antagonistic and/or predacious interaction of the larval stages of
 
certain trematodes infecting the same snail have been studied in detail by
 
Lin and Heyneman (1972) and Lie (1973). These studies have shown that
 
schistosome sporocysts cannot survive the antagonism exhibited by redia­
producing trematode such as echinostomes. Small scale field studies were
 
successfully conducted while others were not successful. Research is still
 
needed to determine if this method is feasible, if other trematodes can be
 
used and if cost-effective methods for mass culture are possible.
 
The principle of competitive interactions which result in exclusion and/
 
or displacement of another species by one which is similar but stronger is a
 
very attractive approach. Before this approach can become successful, more
 
information should be obtained concerning snail-population densities and
 
transmission dynamics.
 
Various species of freshwater snails (Marisa cornnaretis, Helisoma duryi,
 
Pomacea hanstru Physa sp., Melanopsis sp., Thiara granifera, Potamopyrgus
 
jenkinsi and certain species of Bulinus) have been recognized as having potential
 
for use as competitors against schistosome vector snails. The species M.
 
cornuaretis has been studied the most extensively and found to be a competitive
 
feeder and incidental predator on the eggs and junevile of B. qlabrata in Puerto
 
Rico. M. cornuaretis has also been shown to be a predator on Bulinus sp, in
 
experiments conducted in outside concrete troughs in Egypt.
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The Marisa snail was placed into a small dam in Tanzania where heavy
 
populations of B. pfeifferi, Bulinus tropicus and Lymnea natalensis existed
 
and after twenty-four months the three pulmonate species had been eliminated.
 
The snail species Melanopsis has been shown to competitively replace
 
B. truncatus in irrigation canals during a three year study in Algeria.
 
Various investigators have suggested that the snail species, Helisoma
 
duryi appears to have possibilities as an effective competitor when present
 
in certain types of habitats. In many'instances it has been observed that
 
the snail vectors for schistosomes are noticably absent when H. dury_ is
 
present. This possibility is thought to exist in certain areas of Egypt
 
where H. duryi is present in large numbers. More studies concerned with the
 
competitive ability of this species is warranted.
 
The hydrobiid snail P. jenkinsi has been shown to apparently displace 
B. truncatus from its natural habitat in Corsica. These observations need to
 
be confined and extended if possible to other areas where P. jenkinsi may exist.
 
Recent observations by several investigators have indicated that B. 
straminea and B. tenagophila can competitively reduce and/or eliminate pop­
ulations of B. glabrata. The possibility of using these species in Brazil and 
Martinique to at least reduce transmission is a possibility. It is obvious from 
this presentation that all of the biological agents discussed must be exhaustly 
tested for their efficacy in reducing and/or eliminating the target species. to a 
threshold below which transmission ceases to be a health problem. In addition, 
the safety of these successful predators and competitors to man and other non­
target biota must be proven without a doubt. The selected species must be used 
at a level which is cost-effective in the context of the local situation. None 
of the discussed species meet any of the above criteria. 
A scheme devised by Arata (1975) and WHO (1975) for screening and evaluating
 
the most promising organisms for biological control of insects vectors should be
 
adapted for use in attempts to develop a biocontrol of the schistosome snail
 
vectors. What is needed now, is support for purposes of evaluating and sub­
sequent safety and cost effective determinations under carefully defined field
 
conditions.
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The recent resurgence of interest in the use of plant molluscicides
 
deserves mention here even though it is in reference to chemical control.
 
Many vegetable molluscicides (e.g., the bark of Entada phaseoloides, the
 
roots of Derris elliptica and etc.) have been reported as having potential
 
effectiveness against snails but they are also harmful to other life forms.
 
The most studied molluscicide of plant origin is from the berries of the
 
plant endod, the Ethiopian name for the climbing plant (Phytolacca
 
dodecandra. A review and list of recent literature pertaining to endod has
 
been prepared by Lemma, Heyneman and Kloos. Other plant molluscicides which
 
deserve mentioning here are Croton tiglium and C. macrostachys, Ambrosia
 
maritima and the seeds of Jatropha curcas.
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